Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Caroline Atyeo and Galit Alter.
Caroline Atyeo
Connection Strength
5.445
Galit Alter
  1. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. JCI Insight. 2021 01 11; 6(1).
    View in: PubMed
    Score: 0.923
  2. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021 02 04; 184(3):628-642.e10.
    View in: PubMed
    Score: 0.920
  3. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival. Immunity. 2020 09 15; 53(3):524-532.e4.
    View in: PubMed
    Score: 0.895
  4. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. 2021 08; 596(7871):268-272.
    View in: PubMed
    Score: 0.237
  5. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat Commun. 2021 02 15; 12(1):1018.
    View in: PubMed
    Score: 0.232
  6. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat Med. 2021 03; 27(3):454-462.
    View in: PubMed
    Score: 0.232
  7. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. JAMA Netw Open. 2020 12 01; 3(12):e2030455.
    View in: PubMed
    Score: 0.229
  8. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. 2020 12 10; 183(6):1508-1519.e12.
    View in: PubMed
    Score: 0.228
  9. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity. mSphere. 2020 09 02; 5(5).
    View in: PubMed
    Score: 0.225
  10. SARS-CoV-2-specific ELISA development. J Immunol Methods. 2020 Sep - Oct; 484-485:112832.
    View in: PubMed
    Score: 0.224
  11. Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. J Appl Lab Med. 2021 11 01; 6(6):1561-1570.
    View in: PubMed
    Score: 0.061
  12. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med. 2021 08 18; 13(607).
    View in: PubMed
    Score: 0.060
  13. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques. Nature. 2021 08; 596(7872):423-427.
    View in: PubMed
    Score: 0.060
  14. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nat Commun. 2021 06 11; 12(1):3587.
    View in: PubMed
    Score: 0.059
  15. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 04 20; 325(15):1535-1544.
    View in: PubMed
    Score: 0.059
  16. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 06; 594(7862):253-258.
    View in: PubMed
    Score: 0.059
  17. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021 09; 225(3):303.e1-303.e17.
    View in: PubMed
    Score: 0.059
  18. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2. JCI Insight. 2021 03 22; 6(6).
    View in: PubMed
    Score: 0.058
  19. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. 2021 03 09; 54(3):542-556.e9.
    View in: PubMed
    Score: 0.058
  20. Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2021 Feb; 590(7844):E25.
    View in: PubMed
    Score: 0.058
  21. Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19. Hepatol Commun. 2020 Dec 10.
    View in: PubMed
    Score: 0.057
  22. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021 02; 590(7847):630-634.
    View in: PubMed
    Score: 0.057
  23. Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell. 2020 12 10; 183(6):1496-1507.e16.
    View in: PubMed
    Score: 0.057
  24. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020 10 30; 11(1):5493.
    View in: PubMed
    Score: 0.057
  25. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020 10 08; 5(52).
    View in: PubMed
    Score: 0.057
  26. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020 11; 26(11):1694-1700.
    View in: PubMed
    Score: 0.056
  27. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020 10; 586(7830):583-588.
    View in: PubMed
    Score: 0.056
  28. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science. 2020 08 14; 369(6505):806-811.
    View in: PubMed
    Score: 0.055
  29. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020 08 14; 369(6505):812-817.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.